Jin-Xiong She

Dr. Jin-Xiong She is a distinguished biomedical researcher and entrepreneur with over three decades of experience in genomic medicine, aging research, and chronic disease prevention. He earned his undergraduate degree in China and completed his PhD in Molecular and Population Genetics in France.

Throughout his academic career, he held prestigious positions including Endowed Professor and Chief of Experimental Pathology at the University of Florida, where he directed the Diabetes Research Center. In 2002, he was recruited as a Georgia Research Alliance Eminent Scholar in Genomic Medicine at the Medical College of Georgia (now Augusta University), where he founded and directed the Center for Biotechnology and Genomic Medicine. His research has been exceptionally prolific, with over 400 peer-reviewed publications, an H-Index of 74, and more than 17,000 citations.

He has secured over $100 million in research funding and served in numerous leadership roles, including President of the Chinese Geneticists in America and President of the American Diabetes Association's council on Immunology, Transplantation and Immunogenetics. In 2018, Dr. She founded Jinfiniti Precision Medicine, where he serves as Founder, CEO, and Chief Scientific Officer.

The company applies his "4P medicine" philosophy to develop data-driven solutions for healthy longevity. Jinfiniti offers proprietary biomarker testing for aging indicators such as intracellular NAD+ levels, oxidative stress markers, and senescent cell burden, paired with personalized interventions including targeted supplements. His work bridges rigorous scientific methodology with practical health optimization, targeting clinicians, pharmaceutical companies, and the longevity enthusiast community.

Dr. She was recognized as one of Georgia's Top 20 Medical Researchers and has been invited to speak globally on genomics, aging, and longevity. He has mentored 15 doctoral students, over 50 postdoctoral researchers, and 12 faculty members throughout his career.